Dengue Vax Candidate Clears Another Hurdle

12:00 EST 6 Nov 2019 | MedPageToday

(MedPage Today) -- A tetravalent vaccine against dengue virus was effective and appeared safe among healthy children and adolescents, a phase III trial found. In a per-protocol population, vaccine efficacy was 80.2% (95% CI 73.3-85.3) in children...

Original Article: Dengue Vax Candidate Clears Another Hurdle


More From BioPortfolio on "Dengue Vax Candidate Clears Another Hurdle"

Quick Search

Relevant Topics

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one ...

Tropical Medicine
Tropical Medicine is the study of diseases more commonly found in tropical regions than elsewhere. Examples of these diseases are malaria, yellow fever, Chagas disease, Dengue, Helminths, African trypanosomiasis, Leishmaniasis, Leprosy, Lymphatic filaria...

Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...